PL3773750T3 - Preparat i sposób otrzymywania - Google Patents
Preparat i sposób otrzymywaniaInfo
- Publication number
- PL3773750T3 PL3773750T3 PL19713467.9T PL19713467T PL3773750T3 PL 3773750 T3 PL3773750 T3 PL 3773750T3 PL 19713467 T PL19713467 T PL 19713467T PL 3773750 T3 PL3773750 T3 PL 3773750T3
- Authority
- PL
- Poland
- Prior art keywords
- formulation
- preparation
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1804835.5A GB201804835D0 (en) | 2018-03-26 | 2018-03-26 | Formulation and method of preparation |
| PCT/EP2019/057538 WO2019185607A1 (en) | 2018-03-26 | 2019-03-26 | Formulation and method of preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3773750T3 true PL3773750T3 (pl) | 2022-08-08 |
Family
ID=62068063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19713467.9T PL3773750T3 (pl) | 2018-03-26 | 2019-03-26 | Preparat i sposób otrzymywania |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20210046195A1 (pl) |
| EP (1) | EP3773750B1 (pl) |
| JP (2) | JP2021519300A (pl) |
| KR (1) | KR20200136007A (pl) |
| CN (1) | CN112203698A (pl) |
| AU (1) | AU2019246196B2 (pl) |
| BR (1) | BR112020019367A2 (pl) |
| CA (1) | CA3094571A1 (pl) |
| CY (1) | CY1125369T1 (pl) |
| DK (1) | DK3773750T3 (pl) |
| ES (1) | ES2923148T3 (pl) |
| GB (1) | GB201804835D0 (pl) |
| HR (1) | HRP20220850T1 (pl) |
| HU (1) | HUE059216T2 (pl) |
| LT (1) | LT3773750T (pl) |
| MX (1) | MX2020010130A (pl) |
| PL (1) | PL3773750T3 (pl) |
| PT (1) | PT3773750T (pl) |
| RS (1) | RS63388B1 (pl) |
| SG (1) | SG11202009315WA (pl) |
| SI (1) | SI3773750T1 (pl) |
| SM (1) | SMT202200278T1 (pl) |
| WO (1) | WO2019185607A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12180581B2 (en) | 2017-09-18 | 2024-12-31 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| US12181452B2 (en) | 2017-09-18 | 2024-12-31 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| US11709155B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| US11709156B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved analytical analysis |
| US11918936B2 (en) | 2020-01-17 | 2024-03-05 | Waters Technologies Corporation | Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding |
| US12352734B2 (en) | 2020-09-24 | 2025-07-08 | Waters Technologies Corporation | Chromatographic hardware improvements for separation of reactive molecules |
| US12582290B2 (en) | 2021-04-01 | 2026-03-24 | Gyrus Acmi, Inc. | Techniques for composition identification of an anatomical target |
| KR20240105503A (ko) * | 2021-11-26 | 2024-07-05 | 아스테라스 세이야쿠 가부시키가이샤 | 인도시아닌 화합물 함유 고형 의약 조성물 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1046516C (zh) * | 1994-04-25 | 1999-11-17 | 协和发酵工业株式会社 | 化合物dx－52－1的稳定方法和其冻干组合物 |
| ES2396368T3 (es) * | 2003-03-03 | 2013-02-21 | Dyax Corporation | Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos |
| US9283260B2 (en) * | 2006-04-21 | 2016-03-15 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
| ATE551073T1 (de) * | 2007-05-16 | 2012-04-15 | Ge Healthcare As | Markierte hgf-bindende peptide für bildgebung |
| EP2030644A1 (en) * | 2007-08-31 | 2009-03-04 | PARI Pharma GmbH | Aerosols for sinunasal drug delivery |
| GB201013808D0 (en) * | 2010-08-18 | 2010-09-29 | Ge Healthcare Ltd | Peptide radiotracer compositions |
| GB201016206D0 (en) * | 2010-09-27 | 2010-11-10 | Ge Healthcare Ltd | Apoptosis imaging agents |
| GB201020314D0 (en) * | 2010-12-01 | 2011-01-12 | Ge Healthcare Ltd | Apoptosis pet imaging agents |
| GB201103696D0 (en) * | 2011-03-04 | 2011-04-20 | Ge Healthcare Ltd | Technetium labelled peptides |
| GB201314936D0 (en) * | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
| EP3068370A2 (en) * | 2013-11-12 | 2016-09-21 | Galenicum Health S.L. | Stable pharmaceutical compositions |
| GB201322456D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
-
2018
- 2018-03-26 GB GBGB1804835.5A patent/GB201804835D0/en not_active Ceased
-
2019
- 2019-03-26 ES ES19713467T patent/ES2923148T3/es active Active
- 2019-03-26 CN CN201980035582.8A patent/CN112203698A/zh active Pending
- 2019-03-26 LT LTEPPCT/EP2019/057538T patent/LT3773750T/lt unknown
- 2019-03-26 US US17/041,759 patent/US20210046195A1/en not_active Abandoned
- 2019-03-26 SM SM20220278T patent/SMT202200278T1/it unknown
- 2019-03-26 PT PT197134679T patent/PT3773750T/pt unknown
- 2019-03-26 BR BR112020019367-4A patent/BR112020019367A2/pt unknown
- 2019-03-26 SI SI201930276T patent/SI3773750T1/sl unknown
- 2019-03-26 WO PCT/EP2019/057538 patent/WO2019185607A1/en not_active Ceased
- 2019-03-26 JP JP2020551822A patent/JP2021519300A/ja active Pending
- 2019-03-26 PL PL19713467.9T patent/PL3773750T3/pl unknown
- 2019-03-26 HR HRP20220850TT patent/HRP20220850T1/hr unknown
- 2019-03-26 MX MX2020010130A patent/MX2020010130A/es unknown
- 2019-03-26 CA CA3094571A patent/CA3094571A1/en active Pending
- 2019-03-26 RS RS20220663A patent/RS63388B1/sr unknown
- 2019-03-26 AU AU2019246196A patent/AU2019246196B2/en not_active Expired - Fee Related
- 2019-03-26 EP EP19713467.9A patent/EP3773750B1/en active Active
- 2019-03-26 KR KR1020207030557A patent/KR20200136007A/ko not_active Withdrawn
- 2019-03-26 DK DK19713467.9T patent/DK3773750T3/da active
- 2019-03-26 HU HUE19713467A patent/HUE059216T2/hu unknown
- 2019-03-26 SG SG11202009315WA patent/SG11202009315WA/en unknown
-
2022
- 2022-07-13 CY CY20221100484T patent/CY1125369T1/el unknown
-
2023
- 2023-12-21 JP JP2023215576A patent/JP2024045106A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021519300A (ja) | 2021-08-10 |
| AU2019246196A1 (en) | 2020-10-29 |
| BR112020019367A2 (pt) | 2021-02-17 |
| CA3094571A1 (en) | 2019-10-03 |
| SG11202009315WA (en) | 2020-10-29 |
| EP3773750A1 (en) | 2021-02-17 |
| PT3773750T (pt) | 2022-07-12 |
| AU2019246196B2 (en) | 2024-11-14 |
| SI3773750T1 (sl) | 2022-09-30 |
| MX2020010130A (es) | 2021-01-08 |
| SMT202200278T1 (it) | 2022-09-14 |
| LT3773750T (lt) | 2022-07-25 |
| KR20200136007A (ko) | 2020-12-04 |
| JP2024045106A (ja) | 2024-04-02 |
| EP3773750B1 (en) | 2022-04-20 |
| GB201804835D0 (en) | 2018-05-09 |
| HRP20220850T1 (hr) | 2022-10-14 |
| HUE059216T2 (hu) | 2022-10-28 |
| ES2923148T3 (es) | 2022-09-23 |
| RU2020134801A (ru) | 2022-04-27 |
| DK3773750T3 (da) | 2022-07-11 |
| WO2019185607A1 (en) | 2019-10-03 |
| CY1125369T1 (el) | 2025-05-09 |
| US20210046195A1 (en) | 2021-02-18 |
| RS63388B1 (sr) | 2022-08-31 |
| CN112203698A (zh) | 2021-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202009315WA (en) | Formulation and method of preparation | |
| IL253314A0 (en) | Multi-active formulations containing natural ingredients and a method for their preparation/production | |
| GB202010241D0 (en) | A pharmaceuticle formulation of palbociclib and a preparation method thereof | |
| IL276135A (en) | Preparations and methods of use | |
| ZA201708429B (en) | Oral solid formulation containing irinotecan and method of preparing the same | |
| ZA202004531B (en) | Compositions containing thymohydroquinone and their method of preparation | |
| ZA202100780B (en) | Bismuth-thiol compositions and methods of use | |
| PL3373910T3 (pl) | Preparat echinomycyny, sposób wytwarzania i sposób stosowania | |
| GB201809909D0 (en) | Preparation and formulation of drinks | |
| IL276053A (en) | Therapeutic Gard and methods of its use | |
| EP3282857A4 (en) | Human milk compositions and methods of making and using same | |
| IL273690A (en) | Gingivitis vaccine and related preparations and methods of using it | |
| ZA202110050B (en) | Additive formulation and method of using same | |
| SG11202104657RA (en) | Formulation of contrast media and process of preparation thereof | |
| SG11202002351SA (en) | Poloxamer compositions and methods of making and using same | |
| PL3692127T3 (pl) | Substancje pro-zapachowe i sposób ich wytwarzania | |
| GB201810923D0 (en) | Compositions and method of treatment | |
| IL283703A (en) | A polymorphic form of meisoindigo and a different formulation of meisoindigo | |
| GB2571791B (en) | Heat-sink formulation and method of manufacture thereof | |
| PL3692126T3 (pl) | Substancje pro-zapachowe i sposób ich wytwarzania | |
| AU2018904658A0 (en) | Formulation and method of use | |
| AU2018900407A0 (en) | Formulation and method of use | |
| GB201906748D0 (en) | Method of formulation | |
| EP3849576A4 (en) | SEED-BASED FORMULATION AND METHOD OF USE | |
| AU2016900527A0 (en) | Formulation and method of use |